Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Memory Inflation Drives Tissue-Resident Memory CD8+ T Cell Maintenance in the Lung After Intranasal Vaccination With Murine Cytomegalovirus.

Morabito KM, Ruckwardt TJ, Bar-Haim E, Nair D, Moin SM, Redwood AJ, Price DA, Graham BS.

Front Immunol. 2018 Aug 14;9:1861. doi: 10.3389/fimmu.2018.01861. eCollection 2018.

2.

Infants Infected with Respiratory Syncytial Virus Generate Potent Neutralizing Antibodies that Lack Somatic Hypermutation.

Goodwin E, Gilman MSA, Wrapp D, Chen M, Ngwuta JO, Moin SM, Bai P, Sivasubramanian A, Connor RI, Wright PF, Graham BS, McLellan JS, Walker LM.

Immunity. 2018 Feb 20;48(2):339-349.e5. doi: 10.1016/j.immuni.2018.01.005. Epub 2018 Feb 3.

3.

Structural basis of respiratory syncytial virus subtype-dependent neutralization by an antibody targeting the fusion glycoprotein.

Tian D, Battles MB, Moin SM, Chen M, Modjarrad K, Kumar A, Kanekiyo M, Graepel KW, Taher NM, Hotard AL, Moore ML, Zhao M, Zheng ZZ, Xia NS, McLellan JS, Graham BS.

Nat Commun. 2017 Nov 30;8(1):1877. doi: 10.1038/s41467-017-01858-w.

4.

Effect of a package of integrated demand- and supply-side interventions on facility delivery rates in rural Bangladesh: Implications for large-scale programs.

Rahman S, Choudhury AA, Khanam R, Moin SMI, Ahmed S, Begum N, Shoma NN, Quaiyum MA, Baqui AH; Projahnmo Study Group in Bangladesh.

PLoS One. 2017 Oct 26;12(10):e0186182. doi: 10.1371/journal.pone.0186182. eCollection 2017.

5.

Improved Prefusion Stability, Optimized Codon Usage, and Augmented Virion Packaging Enhance the Immunogenicity of Respiratory Syncytial Virus Fusion Protein in a Vectored-Vaccine Candidate.

Liang B, Ngwuta JO, Surman S, Kabatova B, Liu X, Lingemann M, Liu X, Yang L, Herbert R, Swerczek J, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Collins PL, Munir S.

J Virol. 2017 Jul 12;91(15). pii: e00189-17. doi: 10.1128/JVI.00189-17. Print 2017 Aug 1.

6.

Rapid profiling of RSV antibody repertoires from the memory B cells of naturally infected adult donors.

Gilman MS, Castellanos CA, Chen M, Ngwuta JO, Goodwin E, Moin SM, Mas V, Melero JA, Wright PF, Graham BS, McLellan JS, Walker LM.

Sci Immunol. 2016 Dec 16;1(6). pii: eaaj1879. doi: 10.1126/sciimmunol.aaj1879. Epub 2016 Dec 9.

7.

A live RSV vaccine with engineered thermostability is immunogenic in cotton rats despite high attenuation.

Stobart CC, Rostad CA, Ke Z, Dillard RS, Hampton CM, Strauss JD, Yi H, Hotard AL, Meng J, Pickles RJ, Sakamoto K, Lee S, Currier MG, Moin SM, Graham BS, Boukhvalova MS, Gilbert BE, Blanco JC, Piedra PA, Wright ER, Moore ML.

Nat Commun. 2016 Dec 21;7:13916. doi: 10.1038/ncomms13916.

8.

Patterns and Determinants of Care-Seeking for Antepartum and Intrapartum Complications in Rural Bangladesh: Results from a Cohort Study.

Khanam R, Creanga AA, Koffi AK, Mitra DK, Mahmud A, Begum N, Moin SM, Ram M, Quaiyum MA, Ahmed S, Saha SK, Baqui AH; Projahnmo Study Group in Bangladesh.

PLoS One. 2016 Dec 20;11(12):e0167814. doi: 10.1371/journal.pone.0167814. eCollection 2016.

9.

Packaging and Prefusion Stabilization Separately and Additively Increase the Quantity and Quality of Respiratory Syncytial Virus (RSV)-Neutralizing Antibodies Induced by an RSV Fusion Protein Expressed by a Parainfluenza Virus Vector.

Liang B, Ngwuta JO, Herbert R, Swerczek J, Dorward DW, Amaro-Carambot E, Mackow N, Kabatova B, Lingemann M, Surman S, Yang L, Chen M, Moin SM, Kumar A, McLellan JS, Kwong PD, Graham BS, Schaap-Nutt A, Collins PL, Munir S.

J Virol. 2016 Oct 14;90(21):10022-10038. Print 2016 Nov 1.

10.

A Recombinant Respiratory Syncytial Virus Vaccine Candidate Attenuated by a Low-Fusion F Protein Is Immunogenic and Protective against Challenge in Cotton Rats.

Rostad CA, Stobart CC, Gilbert BE, Pickles RJ, Hotard AL, Meng J, Blanco JCG, Moin SM, Graham BS, Piedra PA, Moore ML.

J Virol. 2016 Jul 27;90(16):7508-7518. doi: 10.1128/JVI.00012-16. Print 2016 Aug 15.

11.

Intranasal administration of RSV antigen-expressing MCMV elicits robust tissue-resident effector and effector memory CD8+ T cells in the lung.

Morabito KM, Ruckwardt TR, Redwood AJ, Moin SM, Price DA, Graham BS.

Mucosal Immunol. 2017 Mar;10(2):545-554. doi: 10.1038/mi.2016.48. Epub 2016 May 25.

12.

Implementation of the ANISA Protocol in Sylhet, Bangladesh: Challenges and Solutions.

Mitra DK, Mahmud A, Begum N, Rafiqullah I, Roy A, Moin SM, Islam M, Quaiyum MA, Ferdous J, Applegate JA, Saha SK, Baqui AH.

Pediatr Infect Dis J. 2016 May;35(5 Suppl 1):S55-9. doi: 10.1097/INF.0000000000001108.

PMID:
27070066
13.

Centralized Data Management in a Multicountry, Multisite Population-based Study.

Rahman QS, Islam MS, Hossain B, Hossain T, Connor NE, Jaman MJ, Rahman MM, Ahmed AS, Ahmed I, Ali M, Moin SM, Mullany L, Saha SK, El Arifeen S; ANISA Methods Group.

Pediatr Infect Dis J. 2016 May;35(5 Suppl 1):S23-8. doi: 10.1097/INF.0000000000001102.

PMID:
27070059
14.

Prefusion F-specific antibodies determine the magnitude of RSV neutralizing activity in human sera.

Ngwuta JO, Chen M, Modjarrad K, Joyce MG, Kanekiyo M, Kumar A, Yassine HM, Moin SM, Killikelly AM, Chuang GY, Druz A, Georgiev IS, Rundlet EJ, Sastry M, Stewart-Jones GB, Yang Y, Zhang B, Nason MC, Capella C, Peeples ME, Ledgerwood JE, McLellan JS, Kwong PD, Graham BS.

Sci Transl Med. 2015 Oct 14;7(309):309ra162. doi: 10.1126/scitranslmed.aac4241.

15.

Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection.

Yassine HM, Boyington JC, McTamney PM, Wei CJ, Kanekiyo M, Kong WP, Gallagher JR, Wang L, Zhang Y, Joyce MG, Lingwood D, Moin SM, Andersen H, Okuno Y, Rao SS, Harris AK, Kwong PD, Mascola JR, Nabel GJ, Graham BS.

Nat Med. 2015 Sep;21(9):1065-70. doi: 10.1038/nm.3927. Epub 2015 Aug 24.

PMID:
26301691
16.

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein.

Gilman MS, Moin SM, Mas V, Chen M, Patel NK, Kramer K, Zhu Q, Kabeche SC, Kumar A, Palomo C, Beaumont T, Baxa U, Ulbrandt ND, Melero JA, Graham BS, McLellan JS.

PLoS Pathog. 2015 Jul 10;11(7):e1005035. doi: 10.1371/journal.ppat.1005035. eCollection 2015 Jul.

17.

A subset of membrane-altering agents and γ-secretase modulators provoke nonsubstrate cleavage by rhomboid proteases.

Urban S, Moin SM.

Cell Rep. 2014 Sep 11;8(5):1241-7. doi: 10.1016/j.celrep.2014.07.039. Epub 2014 Aug 21.

18.
19.

An internal water-retention site in the rhomboid intramembrane protease GlpG ensures catalytic efficiency.

Zhou Y, Moin SM, Urban S, Zhang Y.

Structure. 2012 Jul 3;20(7):1255-63. doi: 10.1016/j.str.2012.04.022. Epub 2012 Jun 14.

20.

Intramembrane proteolysis of Toxoplasma apical membrane antigen 1 facilitates host-cell invasion but is dispensable for replication.

Parussini F, Tang Q, Moin SM, Mital J, Urban S, Ward GE.

Proc Natl Acad Sci U S A. 2012 May 8;109(19):7463-8. doi: 10.1073/pnas.1114661109. Epub 2012 Apr 20.

21.

The hepatitis E virus ORF3 protein stabilizes HIF-1alpha and enhances HIF-1-mediated transcriptional activity through p300/CBP.

Moin SM, Chandra V, Arya R, Jameel S.

Cell Microbiol. 2009 Sep;11(9):1409-21. doi: 10.1111/j.1462-5822.2009.01340.x. Epub 2009 Jun 1.

PMID:
19489936
22.

The hepatitis E virus Orf3 protein protects cells from mitochondrial depolarization and death.

Moin SM, Panteva M, Jameel S.

J Biol Chem. 2007 Jul 20;282(29):21124-33. Epub 2007 May 8.

Supplemental Content

Support Center